Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Utah Medical Products stock
Learn how to easily invest in Utah Medical Products stock.
Utah Medical Products Inc is a medical instruments & supplies business based in the US. Utah Medical Products shares (UTMD) are listed on the NASDAQ and all prices are listed in US Dollars. Utah Medical Products employs 181 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Utah Medical Products
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – UTMD – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
Utah Medical Products stock price (NASDAQ: UTMD)Use our graph to track the performance of UTMD stocks over time.
Utah Medical Products shares at a glance
|Latest market close||$95.79|
|52-week range||$79.03 - $131.46|
|50-day moving average||$104.56|
|200-day moving average||$92.45|
|Wall St. target price||N/A|
|Dividend yield||$1.15 (1.24%)|
|Earnings per share (TTM)||$3.85|
Buy Utah Medical Products shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Utah Medical Products stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Utah Medical Products price performance over time
|1 week (2022-01-14)||N/A|
|1 month (2021-12-21)||N/A|
|3 months (2021-10-25)||0.65%|
|6 months (2021-07-23)||10.86%|
|1 year (2021-01-25)||11.38%|
|2 years (2020-01-24)||-7.45%|
|3 years (2019-01-25)||3.89%|
|5 years (2017-01-25)||50.49%|
Is Utah Medical Products stock undervalued or overvalued?
Valuing Utah Medical Products stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Utah Medical Products's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Utah Medical Products's P/E ratio
Utah Medical Products's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 24x. In other words, Utah Medical Products shares trade at around 24x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Utah Medical Products's EBITDA
Utah Medical Products's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $25.3 million.
The EBITDA is a measure of a Utah Medical Products's overall financial performance and is widely used to measure a its profitability.
Utah Medical Products financials
|Revenue TTM||$48.2 million|
|Operating margin TTM||37.45%|
|Gross profit TTM||$25.5 million|
|Return on assets TTM||9.94%|
|Return on equity TTM||13.5%|
|Market capitalisation||$343.7 million|
TTM: trailing 12 months
Utah Medical Products share dividends
Dividend payout ratio: 69.88% of net profits
Recently Utah Medical Products has paid out, on average, around 69.88% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.24% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Utah Medical Products shareholders could enjoy a 1.24% return on their shares, in the form of dividend payments. In Utah Medical Products's case, that would currently equate to about $1.15 per share.
Utah Medical Products's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Utah Medical Products's most recent dividend payout was on 28 December 2021. The latest dividend was paid out to all shareholders who bought their shares by 13 December 2021 (the "ex-dividend date").
Have Utah Medical Products's shares ever split?
Utah Medical Products's shares were split on a 3:2 basis on 21 March 1993. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Utah Medical Products shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Utah Medical Products shares which in turn could have impacted Utah Medical Products's share price.
Utah Medical Products share price volatility
Over the last 12 months, Utah Medical Products's shares have ranged in value from as little as $79.0303 up to $131.4582. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Utah Medical Products's is 0.1586. This would suggest that Utah Medical Products's shares are less volatile than average (for this exchange).
Utah Medical Products overview
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO umbilical vessel catheters; DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; FINESSE+ generators; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS endoscopic irrigation devices; suprapubic catheterization; LIBERTY urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN tool to manipulate the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components, and other molded parts.
Utah Medical Products in the news
Earnings playbook: A complete guide to this week's reports, including the first of tech
Markets are expected to remain on edge as the Fed meets in the week ahead
Netflix quietly admits streaming competition is eating into growth
Frequently asked questionsWhat percentage of Utah Medical Products is owned by insiders or institutions?
Currently 6.744% of Utah Medical Products shares are held by insiders and 72.957% by institutions. How many people work for Utah Medical Products?
Latest data suggests 181 work at Utah Medical Products. When does the fiscal year end for Utah Medical Products?
Utah Medical Products's fiscal year ends in December. Where is Utah Medical Products based?
Utah Medical Products's address is: 7043 South 300 West, Midvale, UT, United States, 84047-1048 What is Utah Medical Products's ISIN number?
Utah Medical Products's international securities identification number is: US9174881089 What is Utah Medical Products's CUSIP number?
Utah Medical Products's Committee on Uniform Securities Identification Procedures number is: 917488108
More guides on Finder
Melania Trump has an NFT — what to know before you buy
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Vigorus (VIS) price prediction
Read our expert analysis on Vigorus and how the token will perform in the future.
Today’s top U.S. stocks: Mechel Pao ADRs (MTL ↑8.1%), Sibanye-Stillwater Limited (SBSW ↑7.4%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
How to order free at-home COVID tests today — but note, there’s a wait
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
Today’s top U.S. stocks: Las Vegas Sands (LVS ↑15.3%), Wynn Resorts Limited (WYNN ↑9.1%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut savings review
Donut earns up to 10% APY, but you must have an iOS device.
Monie savings review
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Is Berkshire Hathaway the next $1 trillion stock?
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Tesla roars into 2022 after December drop
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
Ask an Expert